Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis ; day:29 ; month:11 ; year:2016 ; pages:1-17
Rheumatology and therapy ; (29.11.2016), 1-17
- Urheber
-
Soubrier, Martin
- Beteiligte Personen und Organisationen
-
Pei, Jinglan
Durand, Frédérick
Gullestad, Lars
John, Ani
SpringerLink (Online service)
- DOI
-
10.1007/s40744-016-0049-8
- URN
-
urn:nbn:de:1111-201701146295
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soubrier, Martin
- Pei, Jinglan
- Durand, Frédérick
- Gullestad, Lars
- John, Ani
- SpringerLink (Online service)
Ähnliche Objekte (12)
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
P03-024 – Early onset IBD treated by tocilizumab
Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab
Effect of statins as modulators of CD39+ tregs in patients with rheumatoid arthritis who were unsuccessfully treated with methotrexate
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
P03-024 – Early onset IBD treated by tocilizumab
Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab
Effect of statins as modulators of CD39+ tregs in patients with rheumatoid arthritis who were unsuccessfully treated with methotrexate
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
P03-024 – Early onset IBD treated by tocilizumab
Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab
Effect of statins as modulators of CD39+ tregs in patients with rheumatoid arthritis who were unsuccessfully treated with methotrexate
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources